Pricing Log in Create free account

ICON PLC (ICLR) vs QIAGEN N.V. (QGEN)

ICON PLC and QIAGEN N.V. are both Diagnostics & Research companies. ICON PLC is the larger, with a market value of $15.1B against $10.5B — 1.4× the size. QIAGEN N.V. trades at the lower P/E: 26.1× against 34.5×. QIAGEN N.V. grew revenue faster over the last twelve months: 2.96% against 1.82%. QIAGEN N.V. has the higher net margin (19.5% vs 5.45%) and the higher return on invested capital (6.62% vs 3.84%). Across the 22 metrics below, QIAGEN N.V. leads on 15 and ICON PLC on 7.

Valuation

Metric ICLR QGEN Diagnostics & Research median
P/E 34.48 26.07 34.52
P/S 1.88 5.00 4.24
P/B 1.70 3.13 3.42
Price to free cash flow 18.10 23.83 33.51
EV/EBITDA 17.86 17.43 23.44
EV/Sales 2.35 5.40 5.18
Earnings yield 2.90% 3.84% (1.50%)
Free cash flow yield 5.53% 4.20% 0.00%

Profitability

Metric ICLR QGEN Diagnostics & Research median
Gross margin 23.43% 62.20% 48.32%
Operating margin 8.72% 21.21% (5.68%)
Net margin 5.45% 19.49% (4.10%)
Free cash flow margin 10.41% 20.98% 0.00%
Return on equity 4.86% 11.93% 0.00%
Return on assets 2.74% 6.99% (6.05%)
Return on invested capital 3.84% 6.62% 0.00%

Growth

Metric ICLR QGEN Diagnostics & Research median
Revenue growth (TTM) 1.82% 2.96% 8.99%
EPS growth (last fiscal year) (67.42%) 424.32% 20.36%
Revenue growth, 5-year CAGR 24.15% 2.25% 7.30%
Net income growth, 5-year CAGR (7.15%) 3.42% 0.00%

Health

Metric ICLR QGEN Diagnostics & Research median
Debt to equity 0.37 0.49 0.01
Current ratio 1.32 2.85 2.27
Net debt to EBITDA 3.34 0.84 0.68

Dividend

Metric ICLR QGEN Diagnostics & Research median
Dividend yield — 0.69% 0.67%
Payout ratio — 0.18 0.20

Size

Metric ICLR QGEN Diagnostics & Research median
Market cap 15.11b 10.50b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack